Core Scientific Reports Warrant Exercise

TL;DR

Core Scientific cashed in on some cheap warrants, bringing in $10k.

AI Summary

On November 20, 2024, Core Scientific, Inc. reported the exercise of warrants, resulting in the issuance of 1,000,000 shares of common stock. This exercise involved warrants with an exercise price of $0.01 per share, generating proceeds of $10,000 for the company.

Why It Matters

The exercise of these warrants indicates investor confidence and provides the company with additional capital, potentially strengthening its financial position.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of warrant exercises and does not present new risks.

Key Numbers

• 1,000,000 — Shares Issued (Resulting from warrant exercise)
• $0.01 — Exercise Price (Per share for exercised warrants)
• $10,000 — Proceeds (Generated from warrant exercise)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• November 20, 2024 (date) — Date of earliest event reported
• 1,000,000 (dollar_amount) — Shares of common stock issued
• $0.01 (dollar_amount) — Warrant exercise price per share
• $10,000 (dollar_amount) — Proceeds from warrant exercise

FAQ

Key Financial Figures

• $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20241120.htm (8-K) — 35KB
• core_scientificxannouncesx.htm (EX-99.1) — 16KB
• imagea.jpg (GRAPHIC) — 6KB
• 0001628280-24-049126.txt ( ) — 241KB
• core-20241120.xsd (EX-101.SCH) — 3KB
• core-20241120_def.xml (EX-101.DEF) — 17KB
• core-20241120_lab.xml (EX-101.LAB) — 30KB
• core-20241120_pre.xml (EX-101.PRE) — 17KB
• core-20241120_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On November 20, 2024, the Company issued a press release announcing the approval of lease amendments with the City of Denton to enable high-performance computing expansion. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated November 20 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: November 25, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR